Results 221 to 230 of about 28,482,475 (369)

Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.

Journal of Investigative Dermatology, 2014
P. Riihilä, L. Nissinen, R. Ala‐aho, M. Kallajoki, R. Grénman, S. Meri, S. Peltonen, J. Peltonen, V. Kähäri   +8 more
semanticscholar   +1 more source

CircCCNB1 inhibits vasculogenic mimicry by sequestering NF90 to promote miR‐15b‐5p and miR‐7‐1‐3p processing in nasopharyngeal carcinoma

Molecular Oncology, EarlyView.
CircCCNB1 expression is down‐regulated in nasopharyngeal carcinoma (NPC); thus, less NF90 protein is bound to circCCNB1 and more binds to pri‐miRNAs, blocking their (pri‐miRNAs) binding to DGCR8 and inhibiting the processing and generation of miR‐15b‐5p/miR‐7‐1‐3p. Furthermore, decreased miR‐15b‐5p/miR‐7‐1‐3p promotes the expression of the target genes
Chunmei Fan, Fenghua Tan, Jie Wu, Zhaoyang Zeng, Wenjia Guo, He Huang, Wei Xiong   +6 more
wiley   +1 more source

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H. [PDF]

Front Psychiatry, 2023
Zhang Y, Tang W, Wang W, Xu F, Lu W, Zhang C.   +5 more
europepmc   +1 more source

Factors influencing reactivity of thermal H(T) atoms with solids. I. Physical effects [PDF]

, 1985
Richard E. Ehrenkaufer, Wylie C. Hembree, Alfred P. Wolf   +2 more
openalex   +1 more source

Classification of acute myeloid leukemia based on multi‐omics and prognosis prediction value

Molecular Oncology, EarlyView.
The Unsupervised AML Multi‐Omics Classification System (UAMOCS) integrates genomic, methylation, and transcriptomic data to categorize AML patients into three subtypes (UAMOCS1‐3). This classification reveals clinical relevance, highlighting immune and chromosomal characteristics, prognosis, and therapeutic vulnerabilities.
Yang Song, Zhe Wang, Guangji Zhang, Jiangxue Hou, Kaiqi Liu, Shuning Wei, Yan Li, Chunlin Zhou, Dong Lin, Min Wang, Hui Wei, Jianxiang Wang, Tao Cheng, Yingchang Mi   +13 more
wiley   +1 more source

Factor H: a novel modulator in sickle cell disease

Haematologica, 2019
Wassim El Nemer, Bérengère Koehl
doaj   +1 more source

Novel immunochromatographic test for rapid detection of anti-factor H autoantibodies with an assessment of its clinical relevance. [PDF]

Front Immunol
Rodríguez de Córdoba S, Reparaz A, Sanchez D, Pinto S, Juana Lopez L, Martin Merinero H, Calvete I, Perez-Perez J, Jellison SS, Zhang Y, Smith RJH, Moreno I, Dominguez M.   +12 more
europepmc   +1 more source

Mucha H., E. Keller, H. Weber, F. Lingens and W. Trösch, Sirohydrochlorin, a precursor of factor F₄₃₀ biosynthesis in Methanobacterium thermoautotrophicum (1985) FEBS Letters 190, 169‐171 [PDF]

, 1986

openalex   +1 more source

Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
We aggregated a cohort of 1012 mCRPC tissue samples from 769 patients and investigated the association of gene expression‐based pathways with clinical outcomes. Loss of AR signaling, high proliferation, and a glycolytic phenotype were independently prognostic for poor outcomes, and an adverse transcriptional feature score incorporating these pathways ...
Marina N. Sharifi, Eric Feng, Nicholas R. Rydzewski, Amy K. Taylor, Jamie M. Sperger, Yue Shi, Kyle T. Helzer, Matthew L. Bootsma, Viridiana Carreno, Alex H. Chang, Luke A. Nunamaker, Grace C. Blitzer, Tianfu Andy Shang, Aishwarya Subramanian, Anders Bjartell, Andreas Josefsson, Pernilla Wikström, Emily Feng, Manish Kohli, Rendong Yang, Scott M. Dehm, Eric J. Small, Rahul Aggarwal, David A. Quigley, Joshua M. Lang, Shuang G. Zhao, Martin Sjöström   +26 more
wiley   +1 more source

CspZ variant-specific interaction with factor H incorporates a metal site to support Lyme borreliae complement evasion. [PDF]

J Biol Chem
Brangulis K, Sürth V, Marcinkiewicz AL, Akopjana I, Kazaks A, Bogans J, Huber A, Lin YP, Kraiczy P.   +8 more
europepmc   +1 more source